CANQF — CanaQuest Medical Share Price
Last trade - 00:00- $0.41m
- $0.53m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 20.41 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CanaQuest Medical Corp is a Canada-based biopharmaceutical company specializing in the development of cannabinoid-based therapeutics. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post-Traumatic Stress Disorder (PTSD). It has created a natural formulation derived from cannabidiol + proprietary API composition. The Company is focused on CQ-001, its proprietary drug candidate that combines cannabidiol (CBD) with essential fatty acids (Omega-3s). CQ-001 is positioned for clinical trials targeting epilepsy. The Company is also developing a nutraceutical version of this formulation, called Mentanine, which is scheduled for clinical studies to explore its potential use for various conditions. The Company has a wholly owned subsidiary, ADC BioMedical Corp.
Directors
- Last Annual
- March 31st, 2018
- Last Interim
- March 31st, 2018
- Incorporated
- October 7th, 2008
- Public Since
- October 27th, 2014
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 21,411,377
- Address
- 4120 RIDGEWAY DRIVE, UNIT 37, MISSISSAUGA, L5L 5S9
- Web
- https://ir.canaquest.com/
- Phone
- +1 4167043040
- Auditors
- UHY McGovern Hurley LLP
Upcoming Events for CANQF
Similar to CANQF
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
As of Today at 19:45 UTC, shares in CanaQuest Medical are trading at $0.02. This share price information is delayed by 15 minutes.
Shares in CanaQuest Medical last closed at $0.02 and the price had moved by -75.84% over the past 365 days. In terms of relative price strength the CanaQuest Medical share price has underperformed the S&P500 Index by -78.69% over the past year.
The overall consensus recommendation for CanaQuest Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCanaQuest Medical does not currently pay a dividend.
CanaQuest Medical does not currently pay a dividend.
CanaQuest Medical does not currently pay a dividend.
To buy shares in CanaQuest Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.02, shares in CanaQuest Medical had a market capitalisation of $0.41m.
Here are the trading details for CanaQuest Medical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CANQF
Based on an overall assessment of its quality, value and momentum CanaQuest Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in CanaQuest Medical is $0.71. That is 3597.06% above the last closing price of $0.02.
Analysts covering CanaQuest Medical currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CanaQuest Medical. Over the past six months, its share price has underperformed the S&P500 Index by -43.27%.
As of the last closing price of $0.02, shares in CanaQuest Medical were trading -82.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CanaQuest Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on CanaQuest Medical's directors